Abstract
Hormonal therapy is a potential treatment for hidradenitis suppurativa (HS). However, few data exist describing the efficacy of spironolactone in treatment of HS. To assess whether spironolactone treatment improves HS disease severity and patient-reported pain. We performed a single-center chart review of female patients with HS who were treated with spironolactone between 2000 and 2017. Primary outcome measurements included the HS Physician's Global Assessment (HS-PGA), Hurley staging, inflammatory lesion count, fistula count, and a numeric rating scale for pain. On average, subjects were exposed to 75 mg of spironolactone daily over a 7.1-month follow-up period. Patients achieved significant disease improvement with regard to pain (Δ-1.5 [P = .01]), inflammatory lesions (Δ-1.3 [P = .02]), and HS-PGA score (Δ-0.6 [P < .001]). As expected, no change was found for Hurley stage (Δ0 [P = .32]) or fistulas (Δ0 [P = .73]). There was no difference in improvement between subjects who received less than 75 mg of spironolactone daily (n = 25; average dose, 45 mg/d) and those who received more than 100 mg daily (n = 21; average dose, 112 mg/d). Retrospective nature, limited sample size, and variations in severity measures documented were...Continue Reading
Citations
Jul 18, 2019·Ophthalmology and Therapy·David B RosenPhillip C Hoopes
Oct 12, 2019·Clinical and Experimental Dermatology·C QuinlanR Hughes
Jul 2, 2019·The Australasian Journal of Dermatology·Kevin PhanSaxon D Smith
Jan 23, 2020·Journal of the European Academy of Dermatology and Venereology : JEADV·K T SavageA B Kimball
May 20, 2020·The New England Journal of Medicine·Muthiah Vaduganathan, Scott D Solomon
Jun 9, 2020·The British Journal of Dermatology·S B Hasan, J R Ingram
Sep 5, 2020·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·G NikolakisC C Zouboulis
Mar 21, 2020·Frontiers in Medicine·S Morteza Seyed JafariChristoph Schlapbach
Aug 28, 2020·Clinical and Experimental Dermatology·T N SearleF R Ali
May 11, 2019·American Journal of Clinical Dermatology·Georgios NikolakisChristos C Zouboulis
Mar 14, 2020·Nature Reviews. Disease Primers·Robert SabatKerstin Wolk
Sep 14, 2020·The Journal of Investigative Dermatology·John W FrewVincent Piguet
Oct 12, 2019·Journal of the American Academy of Dermatology·Samantha R GoldburgMichael J Payette
Nov 13, 2019·European Journal of Pharmacology·Sebastian StudentRafał Bułdak
Aug 11, 2020·Journal of the American Academy of Dermatology·Dirk M Elston
May 29, 2021·The British Journal of Dermatology·W YuC P Lu
Jul 15, 2021·Clinical and Experimental Dermatology·K M BabbushS R Cohen
May 16, 2020·Journal of the American Academy of Dermatology·Dirk M Elston
May 15, 2020·Dermatology : International Journal for Clinical and Investigative Dermatology·Lauren A V OrensteinIltefat Hamzavi
Jan 7, 2022·American Journal of Clinical Dermatology·Soha GhanianAfsaneh Alavi
Apr 27, 2021·International Journal of Women's Dermatology·Erin K CollierJennifer L Hsiao
Apr 8, 2020·International Journal of Women's Dermatology·Emily NesbittMarcia Driscoll
Apr 8, 2020·International Journal of Women's Dermatology·Erin CollierJennifer L Hsiao
Feb 8, 2022·International Journal of Dermatology·Miłosz LewandowskiWioletta Barańska-Rybak